4.1 Article

Combination of E2F-1 promoter-regulated oncolytic adenovirus and cytokine-induced killer cells enhances the antitumor effects in an orthotopic rectal cancer model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biotechnology & Applied Microbiology

Recent developments in oncolytic adenovirus-based immunotherapeutic agents for use against metastatic cancers

I-K Choi et al.

CANCER GENE THERAPY (2013)

Article Gastroenterology & Hepatology

Low Rectal Cancer: Classification and Standardization of Surgery

Eric Rullier et al.

DISEASES OF THE COLON & RECTUM (2013)

Article Biotechnology & Applied Microbiology

Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects

Padma Sampath et al.

MOLECULAR THERAPY (2013)

Article Oncology

Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

Ning Ning et al.

CANCER RESEARCH (2012)

Review Medicine, General & Internal

Two Hundred Years of Cancer Research

Vincent T. DeVita et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Pathology

E2F-1 is overexpressed and pro-apoptotic in human hepatocellular carcinoma

Marina Palaiologou et al.

VIRCHOWS ARCHIV (2012)

Article Oncology

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

C. Hontscha et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)

Review Biochemistry & Molecular Biology

Impact of tumor microenvironment on oncolytic viral therapy

Jeffrey Wojton et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Article Medicine, General & Internal

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.

Philip W. Kantoff et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Chemistry, Multidisciplinary

Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24

Yu-mei Wu et al.

ACTA PHARMACOLOGICA SINICA (2009)

Article Biochemistry & Molecular Biology

A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses

J. J. Rojas et al.

GENE THERAPY (2009)

Article Surgery

Novel Murine Model for Colon Cancer: Non-Operative Trans-Anal Rectal Injection

Melissa Donigan et al.

JOURNAL OF SURGICAL RESEARCH (2009)

Review Oncology

Oncolytic viruses: a novel form of immunotherapy

Robin J. Prestwich et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2008)

Review Genetics & Heredity

Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer

Dirk M. Nettelbeck

JOURNAL OF MOLECULAR MEDICINE-JMM (2008)

Article Biochemistry & Molecular Biology

In vivo imaging of lymph node metastasis with telomerase-specific replication-selective adenovirus

Hiroyuki Kishimoto et al.

NATURE MEDICINE (2006)

Article Multidisciplinary Sciences

Synergistic antitumor effects of immune cell-viral biotherapy

SH Thorne et al.

SCIENCE (2006)

Article Biochemistry & Molecular Biology

Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model

VK Gupta et al.

GENE THERAPY (2003)

Review Cell Biology

A revised picture of the E2F transcriptional network and RB function

O Stevaux et al.

CURRENT OPINION IN CELL BIOLOGY (2002)

Review Oncology

The RB and p53 pathways in cancer

CJ Sherr et al.

CANCER CELL (2002)

Article Oncology

Animal model of para-aortic lymph node metastasis

S Tsutsumi et al.

CANCER LETTERS (2001)

Review Cell Biology

The Rb/E2F pathway: expanding roles and emerging paradigms

JW Harbour et al.

GENES & DEVELOPMENT (2000)